Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05MGQ
|
||||
Former ID |
DIB006245
|
||||
Drug Name |
MDX-1342
|
||||
Synonyms |
Anti-CD19 (cancer), MDX/BMS; Anti-CD19 antibody (cancer), Medarex/BMS
|
||||
Drug Type |
Antibody
|
||||
Indication | Leukemia [ICD9: 208.9; ICD10:C90-C95] | Phase 2 | [524501] | ||
Company |
Medarex
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | [530298] | ||
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.